Cipher Pharmaceuticals (TSE:CPH) Stock Price Passes Below 50 Day Moving Average – Should You Sell?

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$14.70 and traded as low as C$14.70. Cipher Pharmaceuticals shares last traded at C$14.80, with a volume of 19,351 shares traded.

Cipher Pharmaceuticals Stock Performance

The company has a debt-to-equity ratio of 41.22, a quick ratio of 2.67 and a current ratio of 2.00. The stock’s 50 day moving average price is C$14.70 and its 200 day moving average price is C$14.59. The company has a market capitalization of C$375.48 million, a P/E ratio of 22.09 and a beta of 1.02.

Cipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) last released its earnings results on Thursday, November 6th. The company reported C$0.21 earnings per share (EPS) for the quarter. The business had revenue of C$17.87 million for the quarter. Cipher Pharmaceuticals had a net margin of 59.92% and a return on equity of 17.93%. As a group, equities analysts expect that Cipher Pharmaceuticals Inc. will post 1.2907348 EPS for the current year.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.